Literature DB >> 16684666

Prophylactic dose of neem (Azadirachta indica) leaf preparation restricting murine tumor growth is nontoxic, hematostimulatory and immunostimulatory.

Enamul Haque1, Ishita Mandal, Smarajit Pal, Rathindranath Baral.   

Abstract

Significant restriction of growth of Ehrlich's carcinoma was observed following prophylactic treatment on Swiss albino mice with neem leaf preparation (NLP-1 unit) once weekly for four weeks. Toxic effects of this particular dose (1 unit), along with 0.5 unit and 2 units of NLP doses, were evaluated on different murine physiological systems. One hundred percent of mice could tolerate 4 injections of 0.5 and 1 unit NLP doses. Body weight, different organ-body weight ratios and physical behavior of treated mice remained completely unchanged during treatment with different NLP doses. All of these NLP doses were observed to stimulate hematological systems as evidenced by the increase in total count of RBC, WBC and platelets and hemoglobin percentage. As histological changes as well as elevation in serum alkaline phosphatase, SGOT, SGPT were not observed in mice treated with three different doses of NLP, the nonhepatotoxic nature of NLP was proved. The level of serum urea remained unaltered and normal architecture of the cortical and medullary parts of the kidney were also preserved after NLP treatment. Increased antibody production against B16 melanoma antigen was detected in mice immunized with 0.5 unit and 1 unit of NLP. Number of splenic T lymphocytes (CD4+ and CD8+) and NK cells were also observed to be increased in mice injected with 0.5 unit and 1 unit of NLP. However, NLP dose of 2 units could not exhibit such immunostimulatory changes; NLP mediated immunostimulation was correlated well with the growth restriction of murine carcinoma. In other words, tumor growth restriction was observed only when mice were injected with immunostimulatory doses of NLP (0.5 unit and 1 unit).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16684666     DOI: 10.1080/08923970600623632

Source DB:  PubMed          Journal:  Immunopharmacol Immunotoxicol        ISSN: 0892-3973            Impact factor:   2.730


  10 in total

1.  Neem leaf glycoprotein partially rectifies suppressed dendritic cell functions and associated T cell efficacy in patients with stage IIIB cervical cancer.

Authors:  Soumyabrata Roy; Shyamal Goswami; Anamika Bose; Krishnendu Chakraborty; Smarajit Pal; Atanu Haldar; Parthasarathi Basu; Jaydip Biswas; Rathindranath Baral
Journal:  Clin Vaccine Immunol       Date:  2011-02-09

2.  Neem leaf preparation enhances Th1 type immune response and anti-tumor immunity against breast tumor associated antigen.

Authors:  Ishita Mandal-Ghosh; Utpala Chattopadhyay; Rathindranath Baral
Journal:  Cancer Immun       Date:  2007-03-30

3.  Novel molecular targets of Azadirachta indica associated with inhibition of tumor growth in prostate cancer.

Authors:  Saswati Mahapatra; R Jeffrey Karnes; Michael W Holmes; Charles Y F Young; John C Cheville; Manish Kohli; Eric W Klee; Donald J Tindall; Krishna Vanaja Donkena
Journal:  AAPS J       Date:  2011-05-11       Impact factor: 4.009

4.  Neem leaf glycoprotein prophylaxis transduces immune dependent stop signal for tumor angiogenic switch within tumor microenvironment.

Authors:  Saptak Banerjee; Tithi Ghosh; Subhasis Barik; Arnab Das; Sarbari Ghosh; Avishek Bhuniya; Anamika Bose; Rathindranath Baral
Journal:  PLoS One       Date:  2014-11-12       Impact factor: 3.240

5.  Neem leaf glycoprotein prevents post-surgical sarcoma recurrence in Swiss mice by differentially regulating cytotoxic T and myeloid-derived suppressor cells.

Authors:  Madhurima Sarkar; Sarbari Ghosh; Avishek Bhuniya; Tithi Ghosh; Ipsita Guha; Subhasis Barik; Jaydip Biswas; Anamika Bose; Rathindranath Baral
Journal:  PLoS One       Date:  2017-04-17       Impact factor: 3.240

6.  Effects of graded levels of Azadirachta indica seed oil on growth performance and biochemical profiles of broiler chickens.

Authors:  Vanessa Mafouo Sonhafouo; Jean Raphaël Kana; Kissel Nguepi Dongmo
Journal:  Vet Med Sci       Date:  2019-03-03

Review 7.  Azadirachta indica A. Juss. In Vivo Toxicity-An Updated Review.

Authors:  Teresa M Braga; Lídia Rocha; Tsz Yan Chung; Rita F Oliveira; Cláudia Pinho; Ana I Oliveira; Joaquim Morgado; Agostinho Cruz
Journal:  Molecules       Date:  2021-01-06       Impact factor: 4.411

Review 8.  Exploring the therapeutic potential of Neem (Azadirachta Indica) for the treatment of prostate cancer: a literature review.

Authors:  Neelu Batra; Vigneshwari Easwar Kumar; Roshni Nambiar; Cristabelle De Souza; Ashley Yuen; Uyen Le; Rashmi Verma; Paramita M Ghosh; Ruth L Vinall
Journal:  Ann Transl Med       Date:  2022-07

9.  Neem leaf glycoprotein activates CD8(+) T cells to promote therapeutic anti-tumor immunity inhibiting the growth of mouse sarcoma.

Authors:  Atanu Mallick; Subhasis Barik; Kuntal Kanti Goswami; Saptak Banerjee; Sarbari Ghosh; Koustav Sarkar; Anamika Bose; Rathindranath Baral
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

10.  Ethanolic Neem (Azadirachta indica) Leaf Extract Prevents Growth of MCF-7 and HeLa Cells and Potentiates the Therapeutic Index of Cisplatin.

Authors:  Chhavi Sharma; Andrea J Vas; Payal Goala; Taher M Gheewala; Tahir A Rizvi; Arif Hussain
Journal:  J Oncol       Date:  2014-01-30       Impact factor: 4.375

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.